These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9762380)

  • 1. Update on drug interactions with azole antifungal agents.
    Lomaestro BM; Piatek MA
    Ann Pharmacother; 1998 Sep; 32(9):915-28. PubMed ID: 9762380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E
    Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azole antimycotics and drug interactions in the perioperative period.
    Saari TI; Olkkola KT
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):441-8. PubMed ID: 20610983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
    Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.
    Galvão EL; Rabello A; Cota GF
    PLoS One; 2017; 12(10):e0186117. PubMed ID: 29016694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.
    Brüggemann RJ; Alffenaar JW; Blijlevens NM; Billaud EM; Kosterink JG; Verweij PE; Burger DM
    Clin Infect Dis; 2009 May; 48(10):1441-58. PubMed ID: 19361301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole antifungals: 35 years of invasive fungal infection management.
    Allen D; Wilson D; Drew R; Perfect J
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.
    Calogiuri G; Garvey LH; Nettis E; Romita P; Di Leo E; Caruso R; Butani L; Foti C
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):144-157. PubMed ID: 31538908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients.
    Billaud EM; Guillemain R; Berge M; Amrein C; Lefeuvre S; Louët AL; Boussaud V; Chevalier P
    Med Mycol; 2010 Nov; 48 Suppl 1():S52-9. PubMed ID: 21067331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation azole antifungal agents.
    Kale P; Johnson LB
    Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal agents. Part II. The azoles.
    Terrell CL
    Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generation azole antifungals in clinical investigation.
    Girmenia C
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1279-95. PubMed ID: 19678798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging azole antifungal agents.
    Sheehan DJ; Hitchcock CA; Sibley CM
    Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
    Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ
    Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic antifungal agents. Drug interactions of clinical significance.
    Albengres E; Le Louët H; Tillement JP
    Drug Saf; 1998 Feb; 18(2):83-97. PubMed ID: 9512916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole: a new triazole antifungal.
    Sabo JA; Abdel-Rahman SM
    Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions during therapy with three major groups of antimicrobial agents.
    Shakeri-Nejad K; Stahlmann R
    Expert Opin Pharmacother; 2006 Apr; 7(6):639-51. PubMed ID: 16556082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.